Beyond the cardiac myofilament: hypertrophic cardiomyopathy- associated mutations in genes that encode...

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Inherited Cardiovascular Diseases

Background:

• Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiovascular disease and a leading cause of sudden cardiac death.
• While sarcomeric gene mutations are common, approximately 50% of HCM patients lack these mutations, suggesting other genetic factors.
• Recent research implicates mutations in calcium-handling proteins in HCM pathogenesis.

Purpose of the Study:

• To explore the role of mutations in calcium-handling proteins as an emerging genetic cause of hypertrophic cardiomyopathy.
• To highlight how these mutations serve as tools for understanding cardiac physiology and disease mechanisms.

Main Methods:

• Review of existing studies linking mutations in specific genes (e.g., TNNC1, PLN, JPH2, RYR2, CASQ2, CALR3, SRI) to HCM.
• Analysis of the implications of these mutations for cardiac calcium handling and myofilament function.
• Examination of the utility of these naturally occurring mutations in elucidating basic cardiac physiology and structure-function relationships.

Main Results:

• Mutations in TNNC1, PLN, and JPH2 are associated with HCM in multiple studies.
• Mutations in RYR2, CASQ2, CALR3, and SRI are also linked to HCM, though further validation is needed.
• These findings establish calcium-handling protein gene mutations as a distinct genetic subset of HCM.

Conclusions:

• Mutations in genes encoding calcium-handling proteins represent an important, emerging genetic cause of hypertrophic cardiomyopathy.
• These genetic insights are crucial for advancing our understanding of cardiac physiology and the molecular mechanisms underlying HCM.
• Further research is warranted to fully elucidate the spectrum and impact of these genetic variants in HCM.